文献速递消化道肿瘤与早癌消化内镜

胃特异性CreERT2介导通路改变的人胃癌亚型小鼠模型

Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
PubMed 文献 · Gastroenterology · 2019-10-01

研究通过Anxa10基因座构建胃特异性他莫昔芬诱导CreERT2小鼠,建立模拟人胃癌染色体不稳定(CIN)和基因组稳定(GS)亚型的三种模型。CIN模型肿瘤呈浸润性腺管形态并肝肺转移,GS-TGFB模型呈低分化弥漫形态和印戒细胞并腹膜播散,GS-Wnt模型呈腺瘤样牙样胃癌。类器官药敏显示GS-TGBF和GS-Wnt对多西他赛更耐药,CIN对trametinib更耐药。

要点

  • Anxa10-CreERT2可实现胃上皮特异性基因修饰。
  • CIN模型模拟肠型胃癌,具肝肺转移潜能。
  • GS-TGFB模型模拟弥漫型胃癌,具腹膜播散。

核心结论

  • 利用胃特异性CreERT2系统建立的小鼠肿瘤在形态上类似人胃癌不同亚型,且局部生长、转移和治疗反应模式不同,可用于研究人胃癌亚型。

研究设计与样本

  • 通过数据库检索鉴定胃上皮独特表达基因Anxa10,构建Anxa10基因座他莫昔芬诱导CreERT2小鼠,并建立三种通路改变模型:CIN小鼠(Anxa10-CreERT2;KrasG12D/+;Tp53R172H/+;Smad4fl/f)、GS-TGBF小鼠(Anxa10-CreERT2;Cdh1fl/fl;KrasG12D/+;Smad4fl/fl)和GS-Wnt小鼠(Anxa10-CreERT2;Cdh1fl/fl;KrasG12D/+;Apcfl/fl)。

主要发现

  • CIN小鼠胃肿瘤具浸润性表型,形成肝和肺转移,肿瘤细胞呈腺管形态,类似人肠型胃癌。
  • GS-TGFB小鼠胃肿瘤低分化、呈弥漫形态并含印戒细胞,类似人弥漫型胃癌;肿瘤细胞具浸润性,小鼠发生腹膜癌病和肺转移。
  • GS-Wnt小鼠发生腺瘤样牙样胃癌。
  • GS-TGBF和GS-Wnt肿瘤来源类器官对多西他赛更耐药,CIN肿瘤来源类器官对trametinib更耐药。

临床怎么用

  • 这些模型可用于研究人胃癌不同亚型的局部生长、转移和对治疗药物的反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patterns of genetic alterations characterize different molecular subtypes of human gastric cancer. We aimed to establish mouse models of these subtypes. METHODS: We searched databases to identify genes with unique expression in the stomach epithelium, resulting in the identification of Anxa10. We generated mice with tamoxifen-inducible Cre recombinase (CreERT2) in the Anxa10 gene locus. We created 3 mouse models with alterations in pathways that characterize the chromosomal instability (CIN) and the genomically stable (GS) subtypes of human gastric cancer: Anxa10-CreERT2;KrasG12D/+;Tp53R172H/+;Smad4fl/f (CIN mice), Anxa10-CreERT2;Cdh1fl/fl;KrasG12D/+;Smad4fl/fl (GS-TGBF mice), and Anxa10-CreERT2;Cdh1fl/fl;KrasG12D/+;Apcfl/fl (GS-Wnt mice). We analyzed tumors that developed in these mice by histology for cell types and metastatic potential. We derived organoids from the tumors and tested their response to chemotherapeutic agents and the epithelial growth factor receptor signaling pathway inhibitor trametinib. RESULTS: The gastric tumors from the CIN mice had an invasive phenotype and formed liver and lung metastases. The tumor cells had a glandular morphology, similar to human intestinal-type gastric cancer. The gastric tumors from the GS-TGFB mice were poorly differentiated with diffuse morphology and signet ring cells, resembling human diffuse-type gastric cancer. Cells from these tumors were invasive, and mice developed peritoneal carcinomatosis and lung metastases. GS-Wnt mice developed adenomatous tooth-like gastric cancer. Organoids derived from tumors of GS-TGBF and GS-Wnt mice were more resistant to docetaxel, whereas organoids from the CIN tumors were more resistant to trametinib. CONCLUSIONS: Using a stomach-specific CreERT2 system, we created mice that develop tumors with morphologic similarities to subtypes of human gastric cancer. These tumors have different patterns of local growth, metastasis, and response to therapeutic agents. They can be used to study different subtypes of human gastric cancer.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Seidlitz T, Chen YT, Uhlemann H, et al. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations. Gastroenterology. 2019. PMID: 31585123. doi:10.1053/j.gastro.2019.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。